APA (7th ed.) Citation

Cohen, S. Y. (2009). Anti-VEGF drugs as the 2009 first-line therapy for choroidal neovascularization in pathologic myopia. Retina (Philadelphia, Pa.), 29(8), 1062. https://doi.org/10.1097/IAE.0b013e3181b1bb1a

Chicago Style (17th ed.) Citation

Cohen, Salomon Y. "Anti-VEGF Drugs as the 2009 First-line Therapy for Choroidal Neovascularization in Pathologic Myopia." Retina (Philadelphia, Pa.) 29, no. 8 (2009): 1062. https://doi.org/10.1097/IAE.0b013e3181b1bb1a.

MLA (9th ed.) Citation

Cohen, Salomon Y. "Anti-VEGF Drugs as the 2009 First-line Therapy for Choroidal Neovascularization in Pathologic Myopia." Retina (Philadelphia, Pa.), vol. 29, no. 8, 2009, p. 1062, https://doi.org/10.1097/IAE.0b013e3181b1bb1a.